All News

Drug Topics Voices

Posts, e-mails, comments, and letters from Drug Topics readers

There are “significant breaches” in safe practices associated with managing hospital patients with external ambulatory pumps, according to a new survey from the Institute for Safe Medication Practices (ISMP).

FDA recently issued a drug safety communication that the labels of sodium-glucose cotransporter-2 (SGLT2) inhibitors include the risks of ketoacidosis and serious urinary tract infections, which can lead to hospitalization.

Months after a manufacturer drew widespread criticism from consumer groups and politicians for raising the price of pyrimethamine (Daraprim) by more than 5000%, Express Scripts, the nation’s largest PBM, has announced it will make the drug available for about $1 per pill.

The American Society of Health-System Pharmacists (ASHP) kicks off its 50th Midyear Clinical Meeting and Exhibition in New Orleans, La., on Sunday, Dec. 6. The five-day meeting will be held at the Ernest N. Morial Convention Center, conveniently located in the Warehouse/Arts District and near the Central Business District and French Quarter.

Although pain relief is a national political issue, healthcare providers still have a moral obligation to ensure that patients have access to all available resources to alleviate their pain.

With the ever-increasing demand for retail pharmacists to fill more scripts in less time, it’s not surprising that the most-read Drug Topics story of November was Anna Leon Guerrero’s blog “Pharmacy staffing levels can threaten patient lives.”

The Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill (UNC-Chapel Hill) has started a pharmacy residency program for graduates interested in pharmacy ownership.

Global spending on medications will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies, according to a new report.

The American Medication Association favors a ban on direct-to-consumer advertising for prescription drugs as part of its policy in an effort to make prescription drugs more affordable. Do you agree?

Early data from a clinical study supported by the National Institutes of Health found that adults with hypertension and at least one other risk factor for heart disease were less likely to have a heart attack, stroke, or heart failure with a reduction of systolic blood pressure to 120 mm Hg.